Clinical Trial Update: Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gabapentin for chronic irritability in neurologically impaired children was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Mood
• Neurologically Impaired

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Gillette Children's Specialty Healthcare | Conditions: Neurologically Impaired, Irritable Mood | Phase 2 | Status: TERMINATED | Results posted: 2019-08-02